Candel Therapeutics, Inc. (CADL)’s CAN-2409 Advances with FDA RMAT Status for Localized Prostate Cancer
Candel Therapeutics, Inc.
No. | Hedge Fund | Shares | Value | Activity | % Port |
---|---|---|---|---|---|
1. | Persistent Asset Partners Xin Huang | 0 | $0 | 0% |
Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$6.00 | 750,000 | $4,500,000.00 | 1,303,752 | 2024-12-16 | Filing | |
$6.00 | 500,000 | $3,000,000.00 | 1,142,406 | 2024-12-16 | Filing | |
$1.92 | 23,950 | $45,984.00 | 152,000 | 2022-12-09 | Filing | |
$1.68 | 3,050 | $5,124.00 | 128,050 | 2022-12-08 | Filing | |
$1.61 | 1,238 | $1,993.18 | 2,738 | 2022-12-08 | Filing |
Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$6.98 | 937 | $6,540.26 | 52,493 | 2025-07-28 | Filing | |
$5.04 | 781 | $3,936.24 | 52,493 | 2025-06-30 | Filing | |
$8.76 | 45,316 | $396,995.35 | 52,493 | 2025-03-18 | Filing | |
$8.76 | 32,146 | $281,672.90 | 96,527 | 2025-03-18 | Filing | |
$9.00 | 400 | $3,601.00 | 225,740 | 2025-03-19 | Filing |
No. | Name | Shares | Value | % Port |
---|---|---|---|---|
1. | 903,970 | $4,574,865 | 0% | |
2. | 776,516 | $3,929,171 | 1.37% | |
3. | 196,631 | $994,953 | 0.12% | |
4. | 86,804 | $439,227 | 0% | |
5. | 24,810 | $125,539 | 0% |